Oligodendroglioma
📧 Sign up to get email alerts when something new happens for Oligodendroglioma.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-27EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) from Les Laboratoires Servier has been authorised by the EMA for certain gliomas, including oligodendroglioma and ast…
-
EMA approval · 2026-07-21EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) has been authorised in the EU for oligodendroglioma and astrocytoma by Les Laboratoires Servier.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Investigational Imaging Technique During Brain Surgery [NA]
A clinical trial evaluating an investigational imaging technique during brain tumor surgery has been suspended. The study involves astrocyto…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children, Adolescents, and Young Adults With Brain Tumors
This trial update describes a pediatric brain tumor study using cerebrospinal fluid cell-free tumor DNA; the study was terminated.
-
EMA approval · 2026-03-18EMA Authorised: Voranigo (vorasidenib) — Les Laboratoires Servier
Voranigo (vorasidenib) has been authorised in the EU for the treatment of oligodendroglioma and astrocytoma, with orphan medicine designatio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas [NA]
A completed trial evaluating temporally-modulated pulsed radiation therapy after prior EBRT in adults with recurrent IDH-mutant gliomas, inc…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma [Phase 1]
Phase 1 study evaluating vorasidenib in combination with pembrolizumab for recurrent or progressive IDH-1 mutant gliomas (astrocytoma and ol…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients [Phase 1]
A Phase 1 trial of the ADAGiO adoptive cellular therapy for adult patients with recurrent or progressive oligodendroglioma; the study is cur…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) [Phase 3]
Phase 3 trial SIGMA is investigating safusidenib as maintenance therapy for IDH1-mutant glioma and related astrocytoma/oligodendroglioma sub…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of the Treatment of Recurrent Malignant Glioma With rQNestin34.5v.2 [Phase 1]
Phase 1 clinical trial update on rQNestin34.5v.2 for recurrent malignant glioma, including glioblastoma and related gliomas, with status cur…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma. [Phase 2]
A Phase 2 clinical trial update for pre-radiation chemotherapy in newly diagnosed high-grade gliomas, including glioblastoma, astrocytoma, a…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma [Phase 2]
Phase 2 clinical trial assessing the combination of All-Trans Retinoic Acid (ATRA) with a PD-1 inhibitor in recurrent IDH-mutant glioma; rec…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). [Phase 3]
Phase 3 clinical trial sponsored by University Hospital Heidelberg to improve brain function and quality of life in patients with newly diag…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery [Phase 3]
A Phase 3 randomized trial assessing delayed radiotherapy in patients with low-grade oligodendroglioma who require a treatment other than su…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas [Phase 2]
A Phase 2 clinical trial from MD Anderson is evaluating chemotherapy and radiation therapy for IDH-wildtype gliomas and non-histological (mo…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Peds CHAMP1ON - Hematopoietic Stem Cell And Monoclonal Antibody PD-1 Blockade for RecurreNt Pediatric High-Grade Glioma [Phase 1]
A Phase 1 clinical trial in pediatric patients with recurrent high-grade glioma evaluating hematopoietic stem cell therapy in combination wi…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms [Phase 1]
Phase I trial update indicates ONC206 is being studied for recurrent and rare primary central nervous system neoplasms and the study is curr…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation [Phase 2]
Phase 2 clinical trial update for vorasidenib in pediatric patients with IDH1/IDH2-mutant grade II astrocytoma or oligodendroglioma; the stu…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for relapsed/refractory intracranial glioma in patients under 22 years, currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: HOBSCOTCH-CA (HOme-Based Self-management and COgnitive Training CHanges Lives in Brain CAncer) [NA]
The HOBSCOTCH-CA trial, a home-based self-management and cognitive training program for brain cancer patients, is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial [Phase 2]
This Phase IIc randomized feasibility pilot trial evaluated cognitive behavioral therapy for insomnia in patients with primary brain tumors …
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Study of How Safe and Effective Tarlatamab is in Brain Cancers [Phase 2]
Phase 2 clinical trial evaluating the safety and effectiveness of tarlatamab in brain cancers is currently recruiting. The study targets ast…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Evaluating the Expression Levels of MicroRNA-10b in Patients With Gliomas
The clinical trial investigating microRNA-10b expression in glioma patients has been terminated.
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: FearLess in NeuroOncology [NA]
Clinical trial update for FearLess in NeuroOncology indicates the study is currently recruiting for patients with glioblastoma and other pri…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Amino Acid PET-based Response Assessment in IDH-mutant Gliomas (APPEAR)
APPEAR is a clinical trial evaluating amino acid PET-based response assessment in IDH-mutant gliomas and is currently recruiting, sponsored …